Reinnervate

Reinnervate

Biotechnology company developing enabling technologies that facilitate research into cell growth and function in vitro.

Launch date
Market cap
-
Enterprise valuation
$528—792k (Dealroom.co estimates May 2014.)
Company register number 04468747
Sedgefield England (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout

£1.6m

Series A

£2.1m

Series B

£1.1m

Early VC

£100k

Seed
Total Funding$6.5m

Recent News about Reinnervate

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.